Research: TUMOR MICROENVIRONMENT: A CATALYZER OF TUMOR GROWTH, AGGRESSIVENESS AND INVASION
EDUCATION
[1212-2023 – 13-12-2023] OPERA PHENIX PLUS Revvity training course
[4-05-2023 – 5-05-2023] Scientific poster presentation presso il I Convegno Nazionale Società Organ-on-Chip
[11/2022 – Attuale] Master Universitario di II livello in Ricerca Clinica, open innovation e market access nell'era digitale (Università Campus Bio-Medico di Roma in collaborazione con Farmaindustria)
[10/2020 – 01/2023] Degree in Medical Biotechnology LM-9 (University of Rome)
[10/2017 – 10/2020] Degree in Biotechnology L-2 (University of Ferrara)
PREVIOUS RESEARCH EXPERIENCE:
[November 2023-Today] Researcher: PhD fellow in Molecular Medicine, University of Rome, (at Regina Elena National Cancer Institute, Translational Oncology Research Unit)
[December 2022-Today] Health Researcher in Translational Oncology Research Unit (head Dr. Giovanni Blandino) in Regina Elena National Cancer Institute, Rome, Italy
[April 2021- January 2022] Researcher in Translational Oncology Research Unit. Supervisor: Dr.ssa Valeria Canu, research field: Oncogenic role of SPAG5 in TNBC
LABORATORY SKILLS:
Cancer cell line and patient-derived 3D culture, Lipofectamine transfection, Colony assay, Serum, plasma, PBMC processing from whole blood, DNA/RNA/miRNA extraction from cell line, whole blood, organoids, fresh tumor and FFPE tissue, mRNA and miRNA retro-trascription, Polimerase Chain Reaction (PCR); Quantitave Real Time PCR (RT-qPCR), Immunofluorescense Assay, Chromatin Immunoprecipitation (ChiP), Western Blotting, Viability assay and IC50/EC50 analysis using PelkinElmer ENSPIRE, Drug Screening using Revvity OPERA PHENIX PLUS.